Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use Cigarettes, E-cigarettes and Cannabis (Co-Tox Study)
Part of paid clinical trials in Buffalo, New York.
- Sponsor
- Roswell Park Cancer Institute
- Study ID
- NCT07167225
- Status
- Recruiting
Conditions
- Cigarette Smoking-Related Carcinoma
- E-Cig Use
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 25 Years
- Healthy Volunteers
- Accepted
Interventions
- Effectiveness of different recruitment approaches — OTHERSubjects will asked which type of recruitment material they've seen when completing the screening survey
- Choice of study completion locations — OTHERsubjects will choose location when coordinator calls to schedule appointment
- Cannabis Engagement Assessment — OTHERSelf reported measure of current cannabis use that contains 30 questions assessing quantity, frequency of use and method of consumption in the past 30 days.
- E-cigarette dependence Scale — OTHERA 22-item questionnaire measuring e-cigarette dependence. Higher scores indicate greater dependence.
- Nicotine dependence Scale — OTHERSelf reported measure of current nicotine use that contains 27 questions assessing quantity, frequency of use in past 6 months
- Co use practices QUestionnaire — OTHERSelf reported measure of nicotine and cannabis use that contains 25 questions assessing quantity, frequency and practices of use in past 30 days
Study Details
This study evaluates the amount of nicotine, cannabis, and toxicants linked to the use of nicotine e-cigarette and/or cannabis products in the blood and urine of young adult users as well as the cannabis and nicotine use behaviors of consumers.
Key Dates
- First listed
- Sep 11, 2025
- Start date
- Apr 3, 2025
- Status verified
- Aug 2026
- Primary completion
- Oct 1, 2028
- Completion
- Oct 1, 2028
Study Design
- Enrollment
- 150 participants (estimated)
Arms
- Arm: E-cigarette consumersPredominant e-cigarette consumers
- Arm: Cannabis consumersPredominant cannabis consumers
- Arm: e-cigarette -cannabis coconsumersConsumers who use both e-cigarettes and cannabis .
- Arm: Cigarette coconsumersPredominant cigarette consumer
- Arm: Cigarette-cannabis coconsumerConsumers who use both Cigarette and cannabis
Primary Outcome Measure
Differences in biomarker levels across groups [ Time Frame: 1 study session lasting 1 hour ]
Central Contacts
- ASK RPCI1-800-767-9355
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Roswell Park Comprehensive Cancer Center | Buffalo | New York | 14263 | ASK RPCI 877-275-7724 |
Find similar trials in Buffalo, NY
By research site
Related Studies
- Reaching Rural Cancer Survivors Who Smoke Using Text-Based ProgramPHASE3 · Recruiting · Alliance for Clinical Trials in Oncology · Kingman, Arizona
- Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy SmokersPHASE2 · Recruiting · National Cancer Institute (NCI) · Tucson, Arizona
- Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking AdultsEARLY_PHASE1 · Recruiting · Roswell Park Cancer Institute · Buffalo, New York
- Understanding Tobacco and Cannabis Co-Use Practices: Initiation, Escalation, and MaintenanceRecruiting · Roswell Park Cancer Institute · Buffalo, New York